Red Flags in Clinical Lab Operations Rise from Recent Court Cases
Guilty plea points to patient data collection, while settlement implicates an undisclosed relationship
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Guilty plea points to patient data collection, while settlement implicates an undisclosed relationship
The board was eliminated as part of a sweeping reordering of the Department of Health and Human Services
A lawyer advises medical laboratories on how to improve their avenues for reporting unethical behavior
A leaked budget document for the next fiscal year suggested non-user fee funding may be up slightly compared to recent years.
The role at this point is theoretical, but our editors asked AI for help in drafting what the position might entail
While still in the early stages, Clinical Lab 2.0’s pitch for this new position fits with the need to better use lab data
However, a new memo instructs federal prosecutors to ‘avoid overreach’ when parties cooperate with authorities
CAP and AMP officials weigh in on plans to push for a legislative- or CLIA-based approach to future LDT oversight
Recent inroads into testing of water for dialysis equipment illustrates Quest’s expanded scope with deals
However, integrated technologies must take into account data protection concerns
Marginal LDT scenarios could be where the FDA focuses on next, a lawyer notes